{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:33:44Z","timestamp":1793504024104,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.aprim.2024.103129","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T14:42:56Z","timestamp":1732718576000},"page":"103129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S1","title":["Prevenci\u00f3n de las enfermedades infecciosas. Actualizaci\u00f3n en vacunas PAPPS 2024"],"prefix":"10.1016","volume":"56","author":[{"given":"Ana Pilar","family":"Javierre Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coro","family":"S\u00e1nchez Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Mart\u00edn Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Aldaz Herce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Javier","family":"G\u00f3mez Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Schwarz Chavarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Garc\u00eda Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Isabel","family":"Guti\u00e9rrez P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Luisa","family":"Morat\u00f3 Agust\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2024.103129_bib0255","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.aprim.2020.08.001","article-title":"Prevenci\u00f3n de las enfermedades infecciosas. Actualizaci\u00f3n en vacunas, 2020","volume":"52","author":"Schwarz Chavarri","year":"2020","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2024.103129_bib0260","doi-asserted-by":"crossref","first-page":"102462","DOI":"10.1016\/j.aprim.2022.102462","article-title":"Prevenci\u00f3n de las enfermedades infecciosas. Actualizaci\u00f3n en vacunas PAPPS 2022","volume":"54","author":"Mart\u00edn Mart\u00edn","year":"2022","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2024.103129_bib0265","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41541-024-00874-4","article-title":"Insights into vaccines for elderly individuals: From the impacts of immunosenescence to delivery strategies","volume":"9","author":"Hou","year":"2024","journal-title":"NPJ Vaccines."},{"key":"10.1016\/j.aprim.2024.103129_bib0270","doi-asserted-by":"crossref","first-page":"9797","DOI":"10.3390\/ijms23179797","article-title":"How can we improve the vaccination response in older people? Part II: Targeting immunosenescence of adaptive immunity cells","volume":"23","author":"Garnica","year":"2022","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.aprim.2024.103129_bib0275","doi-asserted-by":"crossref","first-page":"9880","DOI":"10.3390\/ijms23179880","article-title":"How can we improve vaccination response in old people? Part I: Targeting immunosenescence of innate immunity cells","volume":"23","author":"Aiello","year":"2022","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.aprim.2024.103129_bib0280","unstructured":"Joint press release from WHO and UNICEF: Measles cases across Europe continue to surge, putting millions of children at risk [consultado 29 Jun 2024]. Disponible en: https:\/\/www.who.int\/azerbaijan\/news\/item\/28-05-2024-joint-press-release-from-who-and-unicef--measles-cases-across-europe-continue-to-surge--putting-millions-of-children-at-risk"},{"key":"10.1016\/j.aprim.2024.103129_bib0285","unstructured":"communicable-disease-threats-report-week-24-2024.pdf [consultado 29 Jun 2024]. Disponible en: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/communicable-disease-threats-report-week-24-2024.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0290","unstructured":"CalendarioVacunacion_Todalavida.pdf [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/calendario\/docs\/CalendarioVacunacion_Todalavida.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0295","unstructured":"European Centre for Disease Prevention and Control. Seasonal influenza 2022-2023. En: ECDC. Annual Epidemiological Report for 2023. Stockholm: ECDC; 2023. Disponible en: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/seasonal-influenza-annual-epidemiological-report-2022-2023.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0300","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. 2019 [consultado 29 Jun 2024]. Vacunas de uso humano autorizadas en Espa\u00f1a, combinadas, v\u00edricas. Disponible en: https:\/\/www.aemps.gob.es\/medicamentos-de-uso-humano\/medicamentos-biologicos\/vacunas\/comb_viricas\/"},{"key":"10.1016\/j.aprim.2024.103129_bib0305","unstructured":"Recommended composition of influenza virus vaccines for use in the 2024-2025 northern hemisphere influenza season [consultado 29 Jun 2024]. Disponible en: htps:\/\/www.who.int\/publications\/m\/item\/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2024-2025-northern-hemisphere-influenza-season"},{"key":"10.1016\/j.aprim.2024.103129_bib0310","unstructured":"Vigilancia centinela de Infecci\u00f3n Respiratoria Aguda en Atenci\u00f3n Primaria (IRAs) y en Hospitales (IRAG) Gripe, COVID-19 y VRS, temporada 2022-2023. Espa\u00f1a. De semana 40\/2022 a semana 39\/2023 [consultado 29 Jun 2024]. Disponible en: https:\/\/www.isciii.es\/QueHacemos\/Servicios\/VigilanciaSaludPublicaRENAVE\/EnfermedadesTransmisibles\/Documents\/GRIPE\/INFORMES%20ANUALES\/Informe_ANUAL_SiVIRA_2022-23_08012024.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0315","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/ejhf.2945","article-title":"Influenza vaccination and cardiovascular events in patients with ischaemic heart disease and heart failure: A meta-analysis","volume":"25","author":"Modin","year":"2023","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.aprim.2024.103129_bib0320","unstructured":"RecomendacionesVacunacion_Gripe-Covid19.pdf [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/eu\/areas\/promocionPrevencion\/vacunaciones\/gripe_covid19\/docs\/RecomendacionesVacunacion_Gripe-Covid19.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0325","unstructured":"Ficha t\u00e9cnica Vaxneuvance suspensi\u00f3n inyectable en jeringa precargada [consultado 29 Jun 2024]. Disponible en: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/1211591003\/FT_1211591003.html"},{"key":"10.1016\/j.aprim.2024.103129_bib0330","unstructured":"Ficha t\u00e9cnica Prevenar 20 suspensi\u00f3n inyectable en jeringa precargada [consultado 29 Jun 2024]. Disponible en: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/1211612002\/FT_1211612002.html"},{"key":"10.1016\/j.aprim.2024.103129_bib0335","doi-asserted-by":"crossref","first-page":"7494","DOI":"10.1016\/j.vaccine.2021.10.032","article-title":"A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults \u226565years of age with different prior pneumococcal vaccination","volume":"39","author":"Cannon","year":"2021","journal-title":"Vaccine."},{"key":"10.1016\/j.aprim.2024.103129_bib0340","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1016\/j.vaccine.2021.07.004","article-title":"A phase3, randomized, double-blind study to evaluate the immunogenicity and safety of 3lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49years of age","volume":"39","author":"Klein","year":"2021","journal-title":"Vaccine."},{"key":"10.1016\/j.aprim.2024.103129_bib0345","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1016\/j.vaccine.2023.07.016","article-title":"Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60years in Spain","volume":"41","author":"Cantarero","year":"2023","journal-title":"Vaccine."},{"key":"10.1016\/j.aprim.2024.103129_bib0350","unstructured":"CalendarioVacunacion_GRadultos.pdf [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/calendario\/docs\/CalendarioVacunacion_GRadultos.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0355","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4321\/s2173-92772023000200001","article-title":"Enfermedad meningoc\u00f3cica invasiva. Temporada 2021-2022","volume":"31","author":"Soler-Soneira","year":"2023","journal-title":"Bol Epidemiol\u00f3gico Sem."},{"key":"10.1016\/j.aprim.2024.103129_bib0360","unstructured":"Grupo de trabajo vacunaci\u00f3n frente a enfermedad meningoc\u00f3cica invasiva por serogrupoB de la Ponencia de Programa y Registro de Vacunaciones. Recomendaciones de vacunaci\u00f3n frente a enfermedad meningoc\u00f3cica invasiva por serogrupoB. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, noviembre 2022 [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/comoTrabajamos\/docs\/MenB_2022.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0365","unstructured":"Preguntas_respuestas_Vacunacion_frente_meningitis.pdf [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/docs\/Preguntas_respuestas_Vacunacion_frente_meningitis.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0370","unstructured":"Grupo de trabajo vacunaci\u00f3n frente a EMI de la Ponencia de Programa y Registro de Vacunaciones. Recomendaciones de vacunaci\u00f3n frente a enfermedad meningoc\u00f3cica invasiva. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Consumo y Bienestar Social, marzo 2019 [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/docs\/Recomendaciones_Vacunacion_Meningococo.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0375","first-page":"2304","article-title":"Vacunaci\u00f3n frente al virus del papiloma humano","volume":"14","author":"Javierre Miranda","year":"2018","journal-title":"AMF. Actualizaci\u00f3n en Medicina de Familia."},{"key":"10.1016\/j.aprim.2024.103129_bib0380","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.fmc.2019.05.004","article-title":"Estado actual de las nuevas indicaciones de la vacuna del papiloma humano","volume":"26","author":"G\u00f3mez Marco","year":"2019","journal-title":"FMC. Formaci\u00f3n M\u00e9dica Continuada."},{"key":"10.1016\/j.aprim.2024.103129_bib0385","unstructured":"VPH_recomendaciones_vacunacion_Revisionpauta1dosis.pdf [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/comoTrabajamos\/docs\/VPH_recomendaciones_vacunacion_Revisionpauta1dosis.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0390","unstructured":"Informe_HZ_Espa\u00f1a_1998-2018.pdf [consultado 29 Jun 2024]. Disponible en: https:\/\/www.isciii.es\/QueHacemos\/Servicios\/VigilanciaSaludPublicaRENAVE\/EnfermedadesTransmisibles\/Documents\/archivos%20A-Z\/HERPES%20ZOSTER\/Informe_HZ_Espa%C3%B1a_1998-2018.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0395","doi-asserted-by":"crossref","first-page":"102710","DOI":"10.1016\/j.aprim.2023.102710","article-title":"Vacunaci\u00f3n frente al virus del herpes z\u00f3ster","volume":"55","author":"G\u00f3mez Marco","year":"2023","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2024.103129_bib0400","unstructured":"Grupo de trabajo de vacunaci\u00f3n frente a herpes z\u00f3ster de la Ponencia de Programa y Registro de Vacunaciones. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, marzo 2021 HerpesZoster_RecomendacionesVacunacion.pdf [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/programasDeVacunacion\/docs\/HerpesZoster_RecomendacionesVacunacion.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0405","unstructured":"WHO Director-General's statement at the press conference following IHR Emergency Committee regarding the multi-country outbreak of monkeypox - 23 July 2022 [consultado 29 Jun 2024]. Disponible en: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-statement-on-the-press-conference-following-IHR-emergency-committee-regarding-the-multi--country-outbreak-of-monkeypox--23-july-2022"},{"key":"10.1016\/j.aprim.2024.103129_bib0410","unstructured":"Situacion epidemiologica de los casos de mpox-20240603.pdf [consultado 29 Jun 2024]. Disponible en: https:\/\/www.isciii.es\/QueHacemos\/Servicios\/VigilanciaSaludPublicaRENAVE\/EnfermedadesTransmisibles\/Documents\/archivos%20A-Z\/MPOX\/2024\/SITUACION%20EPIDEMIOLOGICA%20DE%20LOS%20CASOS%20DE%20MPOX-20240603.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0415","unstructured":"Preguntas_y_RespuestasMonkeypox.pdf [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/MonkeyPox\/docs\/Preguntas_y_RespuestasMonkeypox.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0420","unstructured":"La OMS presenta un marco estrat\u00e9gico para mejorar la prevenci\u00f3n y el control de la viruela s\u00edmica [consultado 29 Jun 2024]. Disponible en: https:\/\/www.who.int\/es\/news\/item\/24-05-2024-who-releases-a-strategic-framework-for-enhancing-prevention-and-control-of-mpox"},{"key":"10.1016\/j.aprim.2024.103129_bib0425","doi-asserted-by":"crossref","first-page":"102680","DOI":"10.1016\/j.aprim.2023.102680","article-title":"Manejo desde atenci\u00f3n primaria de la infecci\u00f3n por la viruela del mono (MPOX) en humanos","volume":"55","author":"Arranz Izquierdo","year":"2023","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2024.103129_bib0430","unstructured":"Objetivos_vacunacion_2025.pdf [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/coberturas\/docs\/Objetivos_vacunacion_2025.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0435","unstructured":"Grupo de trabajo de la Ponencia de Programa y Registro de Vacunaciones. Vacunaci\u00f3n en trabajadores sanitarios. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad, 2017. Vacunacion_sanitarios.pdf [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/vacunas\/docs\/Vacunacion_sanitarios.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0440","doi-asserted-by":"crossref","first-page":"e012376","DOI":"10.1136\/bmjgh-2023-012376","article-title":"Are maternal vaccines effective and safe for mothers and infants? A systematic review and meta-analysis of randomised controlled trials","volume":"8","author":"De Bruin","year":"2023","journal-title":"BMJ Glob Health."},{"key":"10.1016\/j.aprim.2024.103129_bib0445","unstructured":"Embarazadas_Preguntas_respuestas_VacunacionGripe.pdf [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/programasDeVacunacion\/embarazadas\/docs\/Embarazadas_Preguntas_respuestas_VacunacionGripe.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0450","unstructured":"Ministerio de Sanidad - \u00c1reas - Salud p\u00fablica - Prevenci\u00f3n de la salud - Vacunaciones - Programa vacunaci\u00f3n - Condiciones de riesgo [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/programasDeVacunacion\/riesgo\/home.htm"},{"key":"10.1016\/j.aprim.2024.103129_bib0455","unstructured":"Grupo de Trabajo utilizaci\u00f3n de nirsevimab frente a infecci\u00f3n por virus respiratorio sincitial de la Ponencia de Programa y Registro de Vacunaciones. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, julio 2023. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/comoTrabajamos\/docs\/Nirsevimab_2023.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0460","unstructured":"Ponencia de Programa y Registro de Vacunaciones. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, 14 de marzo de 2024. Recomendaciones de utilizaci\u00f3n de nirsevimab para la temporada 2024-2025 en Espa\u00f1a. Nirsevimab.pdf [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/comoTrabajamos\/docs\/Nirsevimab.pdf"},{"key":"10.1016\/j.aprim.2024.103129_bib0465","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/cid\/ciad707","article-title":"Safety and immunogenicity of bivalent RSVpreF vaccine coadministered with seasonal inactivated influenza vaccine in older adults","volume":"78","author":"Athan","year":"2024","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.aprim.2024.103129_bib0470","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2024.103129_bib0475","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/infdis\/jiac327","article-title":"Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults: Phase 1\/2 randomized clinical trial","volume":"227","author":"Leroux-Roels","year":"2022","journal-title":"J Infect Dis."},{"key":"10.1016\/j.aprim.2024.103129_bib0480","unstructured":"Abrysvo\u00ae Ficha T\u00e9cnica [consultado 29 Jun 2024]. Disponible en: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/1231752001\/FT_1231752001.html"},{"key":"10.1016\/j.aprim.2024.103129_bib0485","unstructured":"Arexvy\u00ae Ficha t\u00e9cnica [consultado 29 Jun 2024]. Disponible en: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/1231740001\/FT_1231740001.html"},{"key":"10.1016\/j.aprim.2024.103129_bib0490","unstructured":"Mresvia\u00ae Ficha t\u00e9cnica de la FDA [consultado 30 de junio de 2024]. Disponible en: https:\/\/www.fda.gov\/media\/179005\/download"},{"key":"10.1016\/j.aprim.2024.103129_bib0495","unstructured":"Ministerio de Sanidad - \u00c1reas - Consejos Sanitarios Viajero Internacional [consultado 29 Jun 2024]. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/sanidadExterior\/laSaludTambienViaja\/consejosSanitarios\/home.htm"},{"key":"10.1016\/j.aprim.2024.103129_bib0500","unstructured":"CDC Yellow Book 2024 | Travelers\u2019 Health | CDC [consultado 29 Jun 2024]. Disponible en: https:\/\/wwwnc.cdc.gov\/travel\/page\/yellowbook-home"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656724002713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656724002713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T14:08:48Z","timestamp":1733234928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656724002713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":50,"alternative-id":["S0212656724002713"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2024.103129","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevenci\u00f3n de las enfermedades infecciosas. Actualizaci\u00f3n en vacunas PAPPS 2024","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2024.103129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"103129"}}